Evidence map›Paper›PMID 36560154›Full record

ReviewSensors (Basel, Switzerland)2022

Assessment of Immune Status Using Inexpensive Cytokines: A Literature Review and Learning Approaches.

Noor Jamaludeen, Juliane Lehmann, Christian Beyer, Katrin Vogel, Mandy Pierau, Monika Brunner-Weinzierl, Myra Spiliopoulou

Open access · goldAbstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Noor JamaludeenKnowledge Management & Discovery Lab, Otto-von-Guericke University, 39106 Magdeburg, Germany.ORCID 0000-0002-4323-0688
Juliane LehmannKnowledge Management & Discovery Lab, Otto-von-Guericke University, 39106 Magdeburg, Germany.
Christian BeyerKnowledge Management & Discovery Lab, Otto-von-Guericke University, 39106 Magdeburg, Germany.
Katrin VogelDepartment of Experimental Pediatrics, University Hospital, Otto-von-Guericke University, 39120 Magdeburg, Germany.ORCID 0000-0002-2584-7932
Mandy PierauDepartment of Experimental Pediatrics, University Hospital, Otto-von-Guericke University, 39120 Magdeburg, Germany.ORCID 0000-0001-9118-0884
Monika Brunner-WeinzierlDepartment of Experimental Pediatrics, University Hospital, Otto-von-Guericke University, 39120 Magdeburg, Germany.ORCID 0000-0002-6838-3568
Myra SpiliopoulouKnowledge Management & Discovery Lab, Otto-von-Guericke University, 39106 Magdeburg, Germany.ORCID 0000-0002-1828-5759
Otto-von-Guericke-Universität Magdeburg · DE

Funding

the European Union (ERDF---European Regional Development Fund) and the State of Saxony-Anhalt, Germany ZS/2018/10/95201
6 · The paper itself

Abstract

The emergence of point-of-care (POC) testing has lately been promoted to deliver rapid, reliable medical tests in critical life-threatening situations, especially in resource-limited settings. Recently, POC tests have witnessed further advances due to the technological revolution in smartphones. Smartphones are integrated as reliable readers to the POC results to improve their quantitative detection. This has enabled the use of more complex medical tests by the patient him/herself at home without the need for professional staff and sophisticated equipment. Cytokines, the important immune system biomarkers, are still measured today using the time-consuming Enzyme-Linked Immunosorbent Assay (ELISA), which can only be performed in specially equipped laboratories. Therefore, in this study, we investigate the current development of POC technologies suitable for the home testing of cytokines by conducting a PRISMA literature review. Then, we classify the collected technologies as inexpensive and expensive depending on whether the cytokines can be measured easily at home or not. Additionally, we propose a machine learning-based solution to even increase the efficiency of the cytokine measurement by leveraging the cytokines that can be inexpensively measured to predict the values of the expensive ones. In total, we identify 12 POCs for cytokine quantification. We find that Interleukin 1β (IL-1β), Interleukin 3 (IL-3), Interleukin 6 (IL-6), Interleukin 8 (IL-8) and Tumor necrosis factor (TNF) can be measured with inexpensive POC technology, namely at home. We build machine-learning models to predict the values of other expensive cytokines such as Interferon-gamma (IFN-γ), IL-10, IL-2, IL-17A, IL-17F, IL-4 and IL-5 by relying on the identified inexpensive ones in addition to the age of the individual. We evaluate to what extent the built machine learning models can use the inexpensive cytokines to predict the expensive ones on 351 healthy subjects from the public dataset 10k Immunomes. The models for IFN-γ show high results for the coefficient of determination: R2 = 0.743. The results for IL-5 and IL-4 are also promising, whereas the predictive model of IL-10 achieves only R2 = 0.126. Lastly, the results demonstrate the vital role of TNF and IL-6 in the immune system due to its high importance in the predictions of all the other expensive cytokines.

Indexed as

CytokinesPoint-of-Care TestingHumansInterferon-gammaInterleukin-10Interleukin-4Interleukin-5Interleukin-6Self-TestingTumor Necrosis Factor-alphaCytokinesInterferon-gammaInterleukin-10Interleukin-4Interleukin-5Interleukin-6Tumor Necrosis Factor-alphaat homecytokinedecision treeliterature reviewpoint of carePRISMArandom forestregression

Identifiers

PMID36560154
PMCPMC9786078
OpenAlexW4312201688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.